Pressure on HHS to stop drug makers from undermining the role of contract pharmacies in the 340B drug discount program is growing after a bipartisan group of 28 senators on Thursday (Sept. 17) added to the dozens of House lawmakers also calling on HHS Secretary Alex Azar to do something about the actions of a handful of drug companies before their tactics spread. “The pharmaceutical manufacturers that are refusing to offer drug discounts are not just ignoring the federal statute,”...